canadian glp 1 Generic of Novo's GLP-1 arrives in Canada, a 'test case for the world' GLP-1 Drug Trends: Canadian Employers

For example, in a patient with intentional overdose who is also on a GLP-1 agonist, the time to peak concentration of co-ingested agents may be prolonged, complicating risk assessment, decontamination decisions, and timing of antidotal therapies

What is GLP-1

Some of the side effects that patients are complaining of include sudden vision loss, pancreatitis, gastroparesis, and kidney problems

Front Cell Dev

The evidence balance on compounded GLP-1 safety The National Center for Complementary and Integrative Health (NCCIH), the FDA, and multiple medical societies - including the American Diabetes Association - have published guidance noting that compounded GLP-1 preparations carry additional safety uncertainty compared to FDA-approved finished products